- Home
- GERN vs YSG Comparison
GERN vs YSG Comparison
Compare GERN & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- YSG
- Stock Information
- Founded
- GERN 1990
- YSG 2016
- Country
- GERN United States
- YSG China
- Employees
- GERN N/A
- YSG N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- GERN Health Care
- YSG Consumer Discretionary
- Exchange
- GERN Nasdaq
- YSG Nasdaq
- Market Cap
- GERN 823.0M
- YSG 889.0M
- IPO Year
- GERN 1996
- YSG 2020
- Fundamental
- Price
- GERN $1.24
- YSG $7.53
- Analyst Decision
- GERN Buy
- YSG
- Analyst Count
- GERN 7
- YSG 0
- Target Price
- GERN $3.17
- YSG N/A
- AVG Volume (30 Days)
- GERN 7.6M
- YSG 264.9K
- Earning Date
- GERN 11-06-2025
- YSG 11-19-2025
- Dividend Yield
- GERN N/A
- YSG N/A
- EPS Growth
- GERN N/A
- YSG N/A
- EPS
- GERN N/A
- YSG N/A
- Revenue
- GERN $164,447,000.00
- YSG $522,879,337.00
- Revenue This Year
- GERN $172.62
- YSG $24.18
- Revenue Next Year
- GERN $56.87
- YSG $14.76
- P/E Ratio
- GERN N/A
- YSG N/A
- Revenue Growth
- GERN 11877.20
- YSG 11.53
- 52 Week Low
- GERN $1.09
- YSG $3.01
- 52 Week High
- GERN $4.50
- YSG $11.57
- Technical
- Relative Strength Index (RSI)
- GERN 43.70
- YSG 40.08
- Support Level
- GERN $1.19
- YSG $7.50
- Resistance Level
- GERN $1.31
- YSG $7.98
- Average True Range (ATR)
- GERN 0.07
- YSG 0.51
- MACD
- GERN -0.01
- YSG -0.01
- Stochastic Oscillator
- GERN 17.31
- YSG 24.75
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.